About
Technology
Issues
FAQ
Links
Official Page
Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE–TIMI 58 randomised trial
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.